Preclinical hunting ground

With a new dedicated preclinical investment initiative, Pfizer Inc. is hoping to more systematically evaluate and invest in the large number of opportunities that fall between its academic translational research collaborations and its venture arm.

Under the new initiative, known informally as Pfizer's R&D Innovate concept, Pfizer plans to make equity investments and incubate companies with platforms or assets it considers strategically important...